Unlike the innate IFN synthesis pathway that is often dysregulated in viral diseases,10, 11, 56 we have introduced an alternative route for enabling IFN‐β bioavailability via an electrically responsive engineered cell. Here, IFNB1 is linked to viral infectious disease.